How to decrease the cost of pacemaker infection treatment by adopting seemingly costly innovation? A budget impact analysis of a leadless pacemaker implantation
Kardiol Pol
.
2022;80(12):1260-1262.
doi: 10.33963/KP.a2022.0284.
Epub 2022 Dec 27.
Authors
Paweł Syska
1
,
Michał M Farkowski
2
,
Monika Raulinajtys-Grzybek
3
,
Aneta Lis
4
,
Mariusz Pytkowski
1
Affiliations
1
2nd Department of Heart Arrhythmia, National Institute of Cardiology, Warszawa, Poland.
2
2nd Department of Heart Arrhythmia, National Institute of Cardiology, Warszawa, Poland. mfarkowski@gmail.com.
3
Department of Management Accounting, Warsaw School of Economics, Warszawa, Poland.
4
Hospital-based Health Technology Assessment Team, National Institute of Cardiology, Warszawa, Poland.
PMID:
36573599
DOI:
10.33963/KP.a2022.0284
No abstract available
Publication types
Research Support, Non-U.S. Gov't
MeSH terms
Equipment Design
Humans
Pacemaker, Artificial*
Prosthesis Implantation
Treatment Outcome